September 2024 Newsletter
Unlocking AI's potential in drug discovery, Torx Software Q2/Q3 release, and join our hands-on workshop in Boston in November
News
Welcome to the June Cresset Newsletter
In this month's news: Complex kanban grouping available in latest Torx release, Cresset achieves SOC 2 compliance, read our article on ADMET prediction with AI techniques, and much more.
Receive our monthly updates direct to your inbox:
Thank you to those who joined us in Brussels for our annual User Group Meeting, featuring presentations from leading industry researchers presenting the latest science and technology updates in our field. We closed the meeting with a speaker panel discussion focused on Digital Transformation in Drug Discovery.
Dates for the 2025 User Group Meeting will be released soon! Learn more
We are delighted to announce the successful completion of our SOC 2® (System and Organization Controls 2) Type 1 audit, achieving compliance with the leading industry standards for customer data security. This certification assures our clients that their sensitive data and intellectual property are protected by robust information security controls and processes.
Empower clarity and capture complexity with the next generation of Torx Software! With a single click, group your compound tickets to simplify even the most complex board and get a complete view of your project - by Chemist, Series, Priority, DesignSet, even Site!
Cresset are proud to support local organizations and those close to the heart of our colleagues. We have recently sponsored a new boat and outreach initiatives at the City of Cambridge Rowing Club and were delighted last week to have the official naming ceremony, where Cresset's own Chief Financial Officer and City member John Leighton officially launched 'Flare', the new women's eight.
In this new article featured in Drug Target Review, Cresset’s CEO Rob Scoffin explores Free Energy Perturbation (FEP) and its current challenges and limitations. He outlines how continuous advancements and strategic approaches are helping to drive the adoption of FEP methods in drug discovery, and what lies in the future of Free Energy Perturbation.
Read the full article published in Scientific Computing World.
We demonstrate Flare’s dedicated interface and broad range of visual analysis tools in our series of articles.
We look at assessing stability when modeling membrane proteins, and discuss what to look out for in notable symptoms of an unstable protein simulation.
We also demonstrate the importance of mimicking the assay conditions of ionic strength, especially when considering charged ligands, and how this can significantly improve the accuracy of your model.
Missed our webinar on MD? Catch up by requesting the recording.
The upcoming release of Flare is packed with cutting edge science and usability features, including a full integration of Spark™, Cresset’s bioisostere replacement solution, ensemble MM/GBSA on dynamics trajectories for binding free energy predictions, homology modeling, new features for Dynamics and Flare FEP calculations, and much more.
Cresset are due to be attending, exhibiting, and/or presenting at the following events. Further details can be found via our upcoming events schedule.
Milner Therapeutics Symposium
2 July 2024 | Cambridge, UK
RICT 2024
3 - 5 July 2024 | Bordeaux, France
ACS Fall 2024
18 - 22 August 2024 | Denver, USA
EFMC-ISMC 2024
1 - 5 September 2024 | Rome, Italy
24th EuroQSAR
22 - 26 September 2024 | Barcelona, Spain
BioTechX Europe
9 - 10 October 2024 | Basel, Switzerland
[VIEW OUR UPCOMING EVENTS SCHEDULE]